DOCTORATE in GENETICS, ONCOLOGY and CLINICAL MEDICINE (GenOMeC) (GenOMeC)
DOTTORATO DI RICERCA IN GENETICA ONCOLOGIA E MEDICINA CLINICA

UNIVERSITA' DEGLI STUDI  DI SIENA

                                                                                        Home Page

 

Publications during the PhD program

 
Pescucci Chiara        
 

1) A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients.

Longo I, Frints SG, Fryns JP, Meloni I, Pescucci C, Ariani F, Borghgraef M, Raynaud M, Marynen P, Schwartz C, Renieri A, Froyen G.

J Med Genet. 2003 Jan;40(1):11-7.

 

2) Type-IV collagen related diseases.

Pescucci C, Longo I, Bruttini M, Mari F, Renieri A.

J Nephrol. 2003 Mar-Apr;16(2):314-6.

 

3) Rett syndrome: the complex nature of a monogenic disease.

Renieri A, Meloni I, Longo I, Ariani F, Mari F, Pescucci C, Cambi F.

J Mol Med. 2003 Jun;81(6):346-54.

 

4) Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features.

Pescucci C, Meloni I, Bruttini M, Ariani F, Longo I, Mari F, Canitano R, Hayek G, Zappella M, Renieri A.

Clin Genet. 2003 Dec;64(6):497-501.

 

5) Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.

Pescucci C, Mari F, Longo I, Vogiatzi P, Caselli R, Scala E, Abaterusso C, Gusmano R, Seri M, Miglietti N, Bresin E, Renieri A.

Kidney Int. 2004 May;65(5):1598-603.

 

6) Three Rett patients with both MECP2 mutation and 15q11-13 rearrangements.

Longo I, Russo L, Meloni I, Ricci I, Ariani F, Pescucci C, Giordano CT, Canitano R, Hayek G, Zappella M, Neri G, Renieri A, Gurrieri F.

Eur J Hum Genet. 2004 Aug;12(8):682-5.

 

7) Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance.

Taruscio D, Falbo V, Floridia G, Salvatore M, Pescucci C, Cantafora A, Marongiu C, Baroncini A, Calzolari E, Cao A, Castaldo G, Bricarelli FD, Guanti G, Nitsch L, Pignatti PF, Rosatelli C, Salvatore F, Zuffardi O.

Clin Chem Lab Med. 2004;42(8):915-21.

 

8) Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication.

Ariani F, Mari F, Pescucci C, Longo I, Bruttini M, Meloni I, Hayek G, Rocchi R, Zappella M, Renieri A.

Hum Mutat. 2004 Aug;24(2):172-7.

 

9) Chromosomal alterations detected by comparative genomic hybridization in nonfunctioning endocrine pancreatic tumors.

Floridia G, Grilli G, Salvatore M, Pescucci C, Moore PS, Scarpa A, Taruscio D.

Cancer Genet Cytogenet. 2005 Jan 1;156(1):23-30.

 

10) Is Rett syndrome a loss-of-imprinting disorder?

Pescucci C, Meloni I, Renieri A.

Nat Genet. 2005 Jan;37(1):10-1.

 

10) CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms.

Scala E, Ariani F, Mari F, Caselli R, Pescucci C, Longo I, Meloni I, Giachino D, Bruttini M, Hayek G, Zappella M, Renieri A.

J Med Genet. 2005 Feb;42(2):103-7

 

11) Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.

Frascą GM, Onetti-Muda A, Mari F, Longo I, Scala E, Pescucci C, Roccatello D, Alpa M, Coppo R, Li Volti G, Feriozzi S, Bergesio F, Schena FP, Renieri A; Italian Renal Immunopathology Group.

Nephrol Dial Transplant. 2005 Mar;20(3):545-51.

 

12) Germline mosaicism in Rett syndrome identified by prenatal diagnosis.

Mari F, Caselli R, Russo S, Cogliati F, Ariani F, Longo I, Bruttini M, Meloni I, Pescucci C, Schurfeld K, Toti P, Tassini M, Larizza L, Hayek G, Zappella M, Renieri A.

Clin Genet. 2005 Mar;67(3):258-60.

 

13) Non-syndromic X-linked mental retardation: from a molecular to a clinical point of view.

Renieri A, Pescucci C, Longo I, Ariani F, Mari F, Meloni I.

J Cell Physiol. 2005 Jul;204(1):8-20.

 

14) CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome.

Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, Scala E, Longo I, Grosso S, Pescucci C, Ariani F, Hayek G, Balestri P, Bergo A, Badaracco G, Zappella M, Broccoli V, Renieri A, Kilstrup-Nielsen C, Landsberger N.

Hum Mol Genet. 2005 Jul 15;14(14):1935-46.

 

15) [Clinical and genetic features of the Alport 'syndromes'].

Pescucci C, Longo I, Mari F, Scala E, Bruttini M, Caselli R, Renieri A.

G Ital Nefrol. 2005 Sep-Oct;22(5):466-76.

 

16) Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.

Longo I, Scala E, Mari F, Caselli R, Pescucci C, Mencarelli MA, Speciale C, Giani M, Bresin E, Caringella DA, Borochowitz ZU, Siriwardena K, Winship I, Renieri A, Meloni I.

Nephrol Dial Transplant. 2006 Mar;21(3):665-71.

 

17) Optineurin gene is not involved in the common high-tension form of primary open-angle glaucoma.

Ariani F, Longo I, Frezzotti P, Pescucci C, Mari F, Caporossi A, Frezzotti R, Renieri A.

Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1077-82.